CholeSafe System
Symptomatic Gallstone Disease (Cholelithiasis)
Pre-clinicalActive
Key Facts
Indication
Symptomatic Gallstone Disease (Cholelithiasis)
Phase
Pre-clinical
Status
Active
Company
About Ictero Medical
Ictero Medical is pioneering a novel, minimally invasive approach to treating gallstone disease, a condition affecting millions globally. Its core technology, the CholeSafe System, is designed to ablate (destroy) the gallbladder lining in a procedure that is less invasive than traditional surgery, potentially offering a definitive cure with faster recovery and fewer complications. The company is in the development stage, building a team with clinical and engineering expertise to bring this innovative medical device to market. If successful, Ictero could disrupt the standard of care for a highly prevalent surgical condition.
View full company profile